Nuvalent
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1 Broadway Ste 14, Cambridge, Massachuse...Phone Number
(857) 357-7000Website
www.nuvalent.comRevenue
-Stock Symbol
NUVLIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
4
1
1
1
1
About Nuvalent
Nuvalent is a biotechnology company focused on developing precision therapies for non-small-cell lung cancer. Its two lead programs both target cancer genes using enzyme blockers known as kinase inhibitors, with the goal of minimizing a patient's resistance to cancer treatments. The company was founded in 2017 and is headquartered out of Cambridge, MA.Explore more
Nuvalent Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nuvalent your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Nuvalent had a recent Job posting/layoffs
Nuvalent, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Nuvalent
Check if Nuvalent has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Nuvalent recently announced quarterly report
Check out if Nuvalent is spiking on competitors!
Funding: Get notified immidiatlly once Nuvalent has new funding data
Product Launch: Get notified when Nuvalent launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Nuvalent
Compare insights from companies similar to Nuvalent, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nuvalent is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nuvalent is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nuvalent.
Nuvalent financials insights
Gather financial insights about Nuvalent, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Multiple Rounds
$351M
Nuvalent Tech Stack
A closer look at the technologies used by Nuvalent
See more technologies
Most Recent Scoops
Person-Based
Pharmaceuticals, Clinical Operations
Person-Based
Medical Research, Pharmaceuticals, Clinical Operations
Person-Based
Medical Research
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Nuvalent News & Media
Deerfield Management Announces Portfolio Company Nuvalent, Inc. to be Acquired by GSK
NEW YORK, June 10, 2026 /PRNewswire/ -- Deerfield Management, an investment firm dedicated to advancing healthcare, today announced that portfolio company Nuvalent, Inc. has entered into a definitive agreement to be acquired by GSK for $10.6 billion. Nuvalent is a clinical-stage precision...Shareholder Alert: Ademi LLP investigates whether Nuvalent, Inc. is obtaining a Fair Price for Public Shareholders
MILWAUKEE, June 10, 2026 /PRNewswire/ -- Ademi LLP is investigating Nuvalent (NASDAQ: NUVL) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with GSK plc. Click here to learn how to join our investigation and obtain additional...GSK pays $10.6B for cancer biotech Nuvalent in industry's second-biggest buy of the year
Nuvalent Bio is GSK’s third big-ticket purchase this year, after the pharma dropped $2.2 billion in January for RAPT Therapeutics and $950 million in February for 35Pharma.GSK to acquire U.S. cancer drugmaker Nuvalent for $10.6 billion - CNBC
The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers' race to bolster pipelines.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nuvalent
Sign Up For FreeTo access detailed company insights
Nuvalent is a biotechnology company focused on developing precision therapies for non-small-cell lung cancer. Its two lead programs both target cancer genes using enzyme blockers known as kinase inhibitors, with the goal of minimizing a patient's resistance to cancer treatments. The company was founded in 2017 and is headquartered out of Cambridge,... Read More
